Life sciences · Interventional Study
ClinicalTrials.gov · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05183230). This is a study registration, not published results. Lead sponsor: Weill Medical College of Cornell University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 115 participants (ESTIMATED). Conditions: Suicide, Attempted, Suicidal Ideation, Depression. Interventions: BEHAVIORAL: WellPATH-PREVENT; BEHAVIORAL: Optimized WellPATH-PREVENT. Primary outcome measures: Change in Event Related Potential - Late Positive Potential (ERP/LPP) - R61 , Study Entry, Week 6, Week 12; Change in Event Related Potential - Late Positive Potential (ERP/LPP) - R33 , Study Entry, Week 6, Week 12, Week 24; Change in Self-Reported Affect - R61 , Study Entry, Week 6, Week 12; Change in Self-Reported Affect - R33 , Study Entry, Week 6, Week 12, Week 24; Change in Emotion Regulation (Cognitive Reappraisal Subscale of ER Questionnaire) - R61 , Study Entry, Week 6, Week 12; Change in Emotion Regulation (Cognitive Reappraisal Subscale of ER Questionnaire) - R33 , Study Entry, Week 6, Week 12, Week 24; Change in Client Satisfaction with Treatment (CSQ) - R61 , Week 6, Week 12; Change in Client Satisfaction with Treatment (CSQ) - R33 , Week 6, Week 12, Week 24; Change in Suicide Risk - Columbia Suicide Severity Scale (C-SSRS) - R61 , Weekly from Study Entry to Week 12 (R61); Change in Suicide Risk - Columbia Suicide Severity Scale (C-SSRS) - R33 , Weekly from Study Entry to Week 24. Brief summary: The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).